IS THEOPHYLLINE OBSOLETE

被引:25
作者
NEWHOUSE, MT
机构
关键词
D O I
10.1378/chest.98.1.1
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:1 / 3
页数:3
相关论文
共 21 条
[1]   HIGH-DOSE INHALED BUDESONIDE IN THE TREATMENT OF SEVERE STEROID-DEPENDENT ASTHMATICS - A 2-YEAR STUDY [J].
ADELROTH, E ;
ROSENHALL, L ;
GLENNOW, C .
ALLERGY, 1985, 40 (01) :58-64
[3]   THE INFLUENCE OF THEOPHYLLINE ON MAXIMAL RESPONSE TO SALBUTAMOL IN SEVERE CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
BARCLAY, J ;
WHITING, B ;
ADDIS, GJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (05) :389-393
[4]   MAXIMUM ACHIEVABLE BRONCHODILATATION IN ASTHMA [J].
CHAIEB, J ;
BELCHER, N ;
REES, PJ .
RESPIRATORY MEDICINE, 1989, 83 (06) :497-502
[5]   INHALED CORTICOSTEROIDS REDUCE THE SEVERITY OF BRONCHIAL HYPERRESPONSIVENESS IN ASTHMA BUT ORAL THEOPHYLLINE DOES NOT [J].
DUTOIT, JI ;
SALOME, CM ;
WOOLCOCK, AJ .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1987, 136 (05) :1174-1178
[6]   GLUCOCORTICOIDS IN ACUTE ASTHMA - A CRITICAL CONTROLLED TRIAL [J].
FANTA, CH ;
ROSSING, TH ;
MCFADDEN, ER .
AMERICAN JOURNAL OF MEDICINE, 1983, 74 (05) :845-851
[7]  
FURUKAWA CT, 1984, PEDIATRICS, V74, P453
[8]   DETERMINING OPTIMAL THERAPY - RANDOMIZED TRIALS IN INDIVIDUAL PATIENTS [J].
GUYATT, G ;
SACKETT, D ;
TAYLOR, DW ;
CHONG, J ;
ROBERTS, R ;
PUGSLEY, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (14) :889-892
[9]  
GUYATT GH, 1987, AM REV RESPIR DIS, V135, P1069
[10]   MEDIATORS, AIRWAY RESPONSIVENESS, AND ASTHMA [J].
HARGREAVE, FE ;
OBYRNE, PM ;
RAMSDALE, EH .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1985, 76 (02) :272-276